close

Enter

Log in using OpenID

Helicobacter Pylori Diagnostics Market

embed
Helicobacter Pylori Diagnostics Market - Size,
Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces
chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer.
Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood
tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic
assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and
histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease
breath test. Increasing infection prevalence in emerging economies and high demand for point-ofcare testing are major factors driving growth of Helicobacter pylori diagnostics market.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1874
Market players are investing in developing point-of-care and accurate diagnostics products to gain
competitive advantage. For instance, in 2017, Exaleza Bioscience launched Automated BreathID Hp
Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with
99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product
portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc.,
the global leader in point of care diagnostics, in order to expand its product portfolio and geographic
presence. With this acquisition, Abbott could access to Alere’s rapid diagnostics segment, which
includes H. pylori detection kits. However, limitations associated with the currently available
diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance,
urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors
treatment.
Helicobacter is a spiral shaped gram-negative bacteria, causing chronic inflammation and
infection in stomach and duodenum leading to ulceration. H. pylori is found in 50-80% of patients
with gastric ulcers and in 90% of patients with duodenal ulcers. An estimated one in six
individuals infected with H. pylori are expected to eventually develop peptic ulcer disease.
Infected individuals experience long asymptomatic conditions with nearly 70% of individuals
having minimal symptoms such as belching, bloating, nausea, vomiting, abdominal discomfort as
occasional, whereas, major symptoms includes abdominal pain, peptic ulcer, bad breath etc.
Helicobacter infection can be diagnosed by invasive that requires gastric mucosa samples, which
are obtained through endoscopy and used for biopsy or non-invasive tests that requires blood or
stool samples. Invasive tests include immunoassay, rapid urease test, and histology whereas
non-invasive includes stool antigen assays serology tests and urea breath test.
Report includes chapters which deeply display the following deliverable about industry :
• Helicobacter Pylori Diagnostics Market Research Objective and Assumption
• Helicobacter Pylori Diagnostics Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Helicobacter Pylori Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Helicobacter Pylori Diagnostics Market, By Regions
• Helicobacter Pylori Diagnostics Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Helicobacter Pylori Diagnostics Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Helicobacter Pylori Diagnostics Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Helicobacter Pylori Diagnostics Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Inorganic strategies by key players is fuelling growth of the Helicobacter pylori
diagnostics market
Key players involved in the global Helicobacter pylori diagnostics market include
Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel
Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian
Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc.,
and Halyard Health, Inc.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1874
Detailed Segmentation:
• Global Helicobacter Pylori Diagnostics Market, By Test Type:
• Invasive
• Immunoassay
• Rapid Urease Test
• Histology
• Non-invasive
• Stool Antigen Assays
• Serology Tests
• Urea Breath Test
• Global Helicobacter Pylori Diagnostics Market, By End User:
• Hospitals
• Clinics
• Diagnostic Laboratories
• Others
• Global Helicobacter Pylori Diagnostics Market, By Region:
• North America Helicobacter Pylori Diagnostics
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Rushikesh
Rushikesh52   documents Email
Document
Category
Health and Medicine
Views
1
File Size
168 KB
Tags
helicobacter
1/--pages
Report inappropriate content